Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dmitriy V, Seledtsov"'
Autor:
Galina V. Seledtsova, Irina P. Ivanova, A. V. Potyemkin, V. I. Seledtsov, S. V. Mamaev, Dmitriy V. Seledtsov, Vladimir A. Kozlov
Publikováno v:
Bulletin of Experimental Biology and Medicine. 146:133-138
Patients with different forms of multiple sclerosis were treated with a vaccine consisting of myelin-reactive T cells. It was found that after this treatment, lymphocytes from patients acquired the capacity to generate antiidiotypic proliferative res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b050d59fd983ce7eaaf3a270d1269640
https://doi.org/10.1007/s10517-008-0237-9
https://doi.org/10.1007/s10517-008-0237-9
Autor:
O. A. Herzsog, V. I. Seledtsov, Irina P. Ivanova, Galina V. Seledtsova, D. M. Samarin, Vladimir A. Kozlov, Dmitriy V. Seledtsov
Publikováno v:
Bulletin of experimental biology and medicine. 144(4)
Two-staged technology for obtaining polyclonal T cell vaccine intended for the treatment of rheumatoid arthritis is described. Stage 1 includes antigen-dependent cultural selection of patient's T cells and stage 2 consists in their reproduction in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e689b195732e3d2af914c85ba684b703
https://pubmed.ncbi.nlm.nih.gov/18642727
https://pubmed.ncbi.nlm.nih.gov/18642727
Autor:
Galina V. Seledtsova, Dmitriy V. Seledtsov, V. I. Seledtsov, D. M. Samarin, Alexey A. Shishkov, Natalya A. Niza, Mariya A. Felde
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 61(2-3)
The objectives of this phase I–II trial were to assess the toxicity, immunological and clinical responses induced in 37 patients with stage IV colorectal cancer by the subcutaneous administration of a xenogenic polyantigenic vaccine (XPV) prepared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bed4c3978be45de4f9b21444818b3996
https://pubmed.ncbi.nlm.nih.gov/17258887
https://pubmed.ncbi.nlm.nih.gov/17258887
Autor:
Victor I, Seledtsov, Alexey A, Shishkov, Mariya A, Surovtseva, Denis M, Samarin, Galina V, Seledtsova, Natalya A, Niza, Dmitriy V, Seledtsov
Publikováno v:
European journal of dermatology : EJD. 16(6)
The objectives of this phase I-II trial were to assess the toxicity, immunological and clinical responses induced in stage III/IV melanoma patients by the subcutaneous administration of xenogenic polyantigenic vaccine (XPV) prepared from disrupted mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cef0bda3564ff778e5bc7753d1335e22
https://pubmed.ncbi.nlm.nih.gov/17229606
https://pubmed.ncbi.nlm.nih.gov/17229606